Buccoadhesive oxycodone hydrochloride disks: plasma pharmacokinetics in healthy volunteers and clinical study

Kalso, 1990, Morphine and oxycodone hydrochloride in the management of cancer pain, Clin. Pharmacol. Ther., 47, 639, 10.1038/clpt.1990.85 Beaver, 1978, Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone, J. Pharmacol. Exp. Ther., 207, 92 Beaver, 1978, Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine, J. Pharmacol. Exp. Ther., 207, 101 Ripamonti, 1993, Sublingual, buccal, inhalatory and intranasal route of opioids administration, Algos, 10, 14 Withmann, 1984, Sublingual morphine: a novel route of narcotic administration, Am. J. Nurs., 84, 939 Parodi, 1996, Development and characterization of a buccoadhesive dosage form of oxycodone hydrochloride, Drug Dev. Ind. Pharm., 22, 445, 10.3109/03639049609069353 Renzi, 1979, Quantitative GLC determination of oxycodone in human plasma, J. Pharm. Sci., 68, 43, 10.1002/jps.2600680115 Weinstein, 1979, Determination of oxycodone in plasma and identification of a major metabolite, J. Pharm. Sci., 68, 527, 10.1002/jps.2600680441 Smith, 1991, Quantitation of oxycodone in human plasma using high-performance liquid chromatography with electrochemical detection, Ther. Drug Monit., 13, 126, 10.1097/00007691-199103000-00007 Save, 1994, Comparative study of buccoadhesive formulations and sublingual capsules of nifedipine, J. Pharm. Pharmacol., 46, 192, 10.1111/j.2042-7158.1994.tb03776.x Hinson, 1994, Pharmacokinetics, safety and tolerability of flosequinan in patients with hepatic dysfunction, J. Pharm. Sci., 83, 382, 10.1002/jps.2600830323 Laugier, 1994, Determination of acitretin in the skin, in the suction blister, and in plasma, J. Pharm. Sci., 83, 623, 10.1002/jps.2600830505 Leow, 1992, Comparative oxycodone pharmacokinetics in humans after intravenous, oral, and rectal administration, Ther. Drug Monit., 14, 479, 10.1097/00007691-199212000-00008 Beckett, 1970, Kinetics of buccal absorption of some carboxylic acids and the correlation of the rate constants and n-heptane: aqueous phase partition coefficients, J. Pharm. Pharmacol., 22, 15, 10.1111/j.2042-7158.1970.tb08378.x Nagai, 1987, Buccal/gingival drug delivery systems, J. Control. Release, 6, 353, 10.1016/0168-3659(87)90088-5 Knuth, 1993, Hydrogel delivery systems for vaginal and oral applications, Adv. Drug Del. Rev., 11, 137, 10.1016/0169-409X(93)90030-8 Cassidy, 1993, Controlled buccal delivery of buprenorphine, J. Control. Release, 25, 21, 10.1016/0168-3659(93)90091-I Cassidy, 1993, Human transbuccal absorption of diclofenac sodium from a prototype hydrogel delivery device, Pharm. Res., 10, 126, 10.1023/A:1018941517355 Zhang, 1989, Transbuccal permeability of isoproterenol—a dog model, Pharm. Res., 6, S135 Duchateau, 1986, Bioavailability of propranolol after oral, sublingual, and intranasal administration, Pharm. Res., 3, 108, 10.1023/A:1016345504153